A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life

The coronavirus disease 2019 (COVID-19) pandemic caused by infection of SARS-CoV-2 and its variants has posed serious threats to global public health, thus calling for the development of potent and broad-spectrum antivirals. We previously designed and developed a peptide-based pan-coronavirus (CoV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Qianyu, Xia, Shuai, Jiao, Fanke, Wang, Qian, Wang, Rui, Lu, Lu, Jiang, Shibo, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028128/
https://www.ncbi.nlm.nih.gov/pubmed/35458385
http://dx.doi.org/10.3390/v14040655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028128/
https://www.ncbi.nlm.nih.gov/pubmed/35458385
http://dx.doi.org/10.3390/v14040655

Ejemplares similares